Newsnation
@newsnation·2.7M subscribers·86.7K videos
New Alzheimer’s drug expected to get FDA approval | Morning in America
Posted
July 4, 2023
Views
1,289
Likes
34
Comments
15
Engagement
3.80%
July 4, 2023
1,289
34
15
3.80%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
5:38Now PlayingThe drug, Leqembi, received conditional approval from the FDA in January based on early results suggesting it could slow Alzheimer’s progression by several months. Robert Vassar, Ph.D. discusses how this drug stands out from other Alzheimer's drugs.
Watch #MorningInAmerica
#Alzheimers #Leqembi #FDA
Start your day with "Morning in America," NewsNation's live three-hour national morning newscast hosted by Adrienne Bankert. Weekdays starting at 7a/6C. #MorningInAmerica
NewsNation is your source for fact-based, unbiased news for all America.
More from NewsNation
Get our app
Find us on cable
How to watch on TV or streaming
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
